Prenumeration
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
1.6.2021 17:00:00 CEST | ViroGates | Managers' transactions
COMPANY ANNOUNCEMENT - No. 14-2021 - 01 June 2021
BIRKERØD, DENMARK - ViroGates A/S, a medical technology company developing blood tests for better triaging in hospitals to improve patient care and reduce healthcare costs, announces the following transactions by persons discharging managerial responsibilities according to MAR art. 19
Navn | Jakob Knudsen |
Årsag til indberetningen | |
Stilling/titel | CEO |
Første indberetning/ændring | Første indberetning |
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplat- formen, auktionsholderen eller den auktionstilsynsførende | |
Navn | ViroGates A/S |
LEI-kode | 5493007TX8XS56RMZD94 |
Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner | |
Beskrivelse af det finansielle instrument, instrumenttypen Identifikationskode | Aktier DK0061030574 |
Transaktionens art | Salg |
Pris(er) | mængde(r) |
207 | 1.881 |
Aggregerede oplysninger - Aggregeret mængde - Pris | 1.881 DKK 389.367 |
Dato for transaktionen | 28/05-2021 |
Sted for transaktionen | Nasdaq First North Growth Market Denmark (DSME) |
Navn | Jakob Knudsen |
Årsag til indberetningen | |
Stilling/titel | CEO |
Første indberetning/æn- dring | Første indberetning |
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplat- formen, auktionsholderen eller den auktionstilsynsførende | |
Navn | ViroGates A/S |
LEI-kode | 5493007TX8XS56RMZD94 |
Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner | |
Beskrivelse af det finansielle instrument, instrumenttypen
Identifikationskode | Aktier
DK0061030574 |
Transaktionens art | Salg |
Pris(er) | Mængd(er) |
202,888 | 500 |
204,5375 | 400 |
Aggregerede oplysninger - Aggregeret mængde - Pris | 900 stk. DKK 183.259 |
Dato for transaktionen | 31/05-2021 |
Sted for transaktionen | Nasdaq First North Growth Market Denmark (DSME) |
The announcement can be found at https://www.virogates.com/investor/announcements
For further information, please contact:
ViroGates A/S:
CFO, Mark da Silva
Tel. (+45) 61635600, email: mds@virogates.com
Certified Advisor:
Västra Hamnen Corporate Finance
Per Lönn
Tel. (+46) 40 200 250, email: per.lonn@vhcorp.se
About ViroGates
ViroGates A/S is an international medical technology company developing and marketing blood test products under the suPARnostic® brand for better triaging in hospitals to improve patient care, reduce healthcare costs and empower clinical staff.
ViroGates’ shares (VIRO) are listed on Nasdaq First North Growth Market Denmark. For more information, please visit www.virogates.com.
Disclosure regulation
Prospects about the future reflect ViroGates' current expectations for future events and results. The statements are by nature inherent in risks, uncertainties and other matters that are difficult to predict or out of control. The actual results may therefore differ from the expectations expressed.
Contacts
- Mark da Silva, CFO, +45 6163 5600, mds@virogates.com